BURLINGTON, Mass. , Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025 . The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company ' s announcement in the first fiscal quarter of 2025 of its intention to pursue a sale. Quarter Ended Dollars in millions, except per share data... Read More

BURLINGTON, Mass. , July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for Frenova's transformative MyReason® genomics research program. This strategic collaboration aims to leverage cutting-edge technologies to... Read More

BURLINGTON, Mass. , July 30, 2025 /PRNewswire/ -- Azenta, Inc . (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, on Tuesday, August 12, 2025 . About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful... Read More

BURLINGTON, Mass. , July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025 , on Tuesday August 5, 2025 , before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, August 5, 2025 , at 8:30 a.m. Eastern Time . Analysts, investors and members of the media can access... Read More

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass. , May 13, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial intelligence (AI) life... Read More

BURLINGTON, Mass. , May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025 . The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company ' s announcement in the first fiscal quarter of 2025 of its intention to pursue a sale. Quarter Ended Dollars in millions, except per share... Read More

BURLINGTON, Mass. , April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025 , on Wednesday May 7, 2025 , before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, May 7, 2025 , at 8:30 a.m. Eastern Time . Analysts, investors and members of the media can access... Read More

BURLINGTON, Mass. , March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2024 . The report offers a comprehensive look at the... Read More

BURLINGTON, Mass. , March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y. Lin , Executive Vice President and Chief Financial Officer, will participate in the Virtual KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025 , which includes a presentation beginning at 10:30 am ET . The live webcast can be accessed through the Azenta investor relations website at... Read More

BURLINGTON, Mass. , Feb. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2024 . The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company ' s announcement in the fourth fiscal quarter of 2024 of its intention to pursue a sale. Quarter Ended Dollars in millions, except per share... Read More

BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi , Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today. Mr. Doshi was nominated for election by the Board, together with nine... Read More

BURLINGTON, Mass. , Jan. 27, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024 , on Wednesday February 5, 2025 , before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, February 5, 2025 , at 8:30 a.m. Eastern Time . Analysts, investors and members of the media... Read More

BURLINGTON, Mass. , Jan. 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in support of the preservation of internationally significant sample collections. This new system is in addition to the seven Azenta BioArc™ Flex™ automated sample store systems already in place at the facility. UK... Read More

BURLINGTON, Mass. , Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024 , which includes a presentation beginning at 1:00 pm CT . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will be available... Read More

FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics FY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points Pursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitability Announces appointment of Lawrence Y. Lin as Chief Financial Officer; Herman... Read More

BURLINGTON, Mass. , Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024 , on Tuesday, November 12, 2024 , after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, November 12, 2024 , at 4:30 p.m. Eastern Time . Analysts, investors and... Read More

William L. Cornog , Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board Comprised of New Directors, CEO John Marotta, and Current Director Martin Madaus Reaffirms Full-Year 2024 Financial Guidance BURLINGTON, Mass. , Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today... Read More

BURLINGTON, Mass. , Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome... Read More

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. , Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024 , succeeding Dr. Stephen Schwartz , who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and... Read More

BURLINGTON, Mass. , Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20 . GENEWIZ Week will showcase our commitment to providing cutting-edge solutions to researchers worldwide through a series of workshops, an awards program,... Read More

BURLINGTON, Mass. , Aug. 6, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2024 . Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2024 2024 2023 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 173 $ 159 $ 166 9 % 4 % Organic growth 5 % Sample Management Solutions $ 81 $ 74 $ 75 9 % 7 % Multiomics $ 64... Read More

BURLINGTON, Mass. , Aug. 5, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, on Monday, August 12, 2024 . About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta... Read More

BURLINGTON, Mass. , July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024 , on Tuesday, August 6, 2024 , after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, August 6, 2024 , at 4:30 p.m. Eastern Time . Analysts, investors and members of the media can access... Read More

Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. , July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland . The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a... Read More

Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass. , June 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn's & Colitis Foundation (the "Foundation") as its sample management services provider for two of its large-scale... Read More

BURLINGTON, Mass. , May 23, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY , on Wednesday, June 5, 2024 , which includes a presentation beginning at 11:00 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast... Read More

BURLINGTON, Mass. , May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK , expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. The new laboratory brings Azenta closer to UK-based researchers,... Read More

CEO Dr. Stephen Schwartz to Retire; Search Underway to Identify Successor BURLINGTON, Mass. , May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwartz will be retiring from Azenta after more than 14 years of service. Dr. Schwartz will continue to serve as CEO until a successor is appointed to ensure a smooth transition. Dr.... Read More

BURLINGTON, Mass. , May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2024 . Quarter Ended Dollars in millions, except per share data March 31, December 31, March 31, Change 2024 2023 2023 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 159 $ 154 $ 148 3 % 7 % Organic growth 7 % Sample Management Solutions $ 74 $ 79 $ 71 (6) % 4 %... Read More

BURLINGTON, Mass. , May 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings which ended on March 31, 2024 , on Wednesday, May 8, 2024 , after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, May 8, 2024 , at 4:30 p.m. Eastern Time . Conference call participants may access the call using... Read More

BURLINGTON, Mass. , April 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2023 . The report offers a comprehensive look at the... Read More

BURLINGTON, Mass. , April 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual Needham Virtual Healthcare Conference, on Monday, April 8, 2024 , which includes a presentation beginning at 12:45 pm ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will be... Read More

BURLINGTON, Mass. , March 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Virtual KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024 , which includes a presentation beginning at 12:45 pm ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will... Read More

BURLINGTON, Mass. , Feb. 7, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023 . Quarter Ended Dollars in millions, except per share data December 31, September 30, December 31, Change 2023 2023 2022 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 154 $ 172 $ 178 (10) % (13) % Organic growth (15) % Sample Management Solutions $ 79 $ 82 $ 75... Read More

BURLINGTON, Mass. , Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the... Read More

BURLINGTON, Mass. , Jan. 25, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2024 earnings which ended on December 31, 2023 , on Wednesday, February 7, 2024 , after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, February 7, 2024 , at 4:30 p.m. Eastern Time . To participate in the conference call,... Read More

BURLINGTON, Mass. , Jan. 11, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Thursday, March 14, 2024 in New York City . The event will feature presentations from members of the executive leadership team outlining the Company's strategy and vision. A live webcast of the event will be available on the Investor Relations section of Azenta's website at... Read More

BURLINGTON, Mass. , Jan. 9, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 26th Annual Needham Growth Conference in New York, NY , on Thursday, January 18, 2024 , which includes a presentation beginning at 10:15 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the... Read More

BURLINGTON, Mass. , Jan. 3, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA , on Thursday, January 11, 2024 , at 7:30 am PST . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will be available following... Read More

BURLINGTON, Mass. , Nov. 21, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL , on Wednesday, November 29, 2023 . About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market... Read More

Q4'23 reported revenue growth of 25% year over year and 2% on an organic basis FY'23 reported revenue growth of 20% and down 1% on an organic basis Q4'23 generated positive free cash flow for the second consecutive quarter Fiscal 2024 organic revenue growth expected to be 5-8% Committing to an additional $500 million in share repurchases in Fiscal 2024 BURLINGTON, Mass. , Nov. 13, 2023 /PRNewswire/ -- Azenta , Inc. ( Nasdaq... Read More

Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven of the Board of Directors' ten members will have been added since 2018 Separately, Azenta today announced strong 2023 fourth quarter and full year fiscal 2023 earnings results, with commitment to additional $500 million in share repurchases in Fiscal 2024 BURLINGTON, Mass. , Nov. 13, 2023... Read More

BURLINGTON, Mass. , Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that B Medical Systems S.à r.l ("B Medical") and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo (DRC) (the "Ministry") have entered into a Memorandum of Understanding ("MOU") for B Medical to deliver a complete solution suitable for the storage and transport of vaccines with real-time... Read More

BURLINGTON, Mass. , Nov. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee , on Wednesday, November 15, 2023 , and Thursday, November 16, 2023 . The company will host a presentation on Thursday, November 16, 2023 , beginning at 11:00 am CT . The live webcast can be accessed through the Azenta... Read More

BURLINGTON, Mass. , Nov. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2023 earnings which ended on September 30, 2023 on Monday, November 13, 2023 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 13, 2023 , at 4:30 p.m. Eastern Time . To participate in the conference... Read More

BURLINGTON, Mass. , Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week November 6-10, 2023 . The weeklong event will feature various virtual educational workshops, exclusive promotions, and a special grant program to recognize excellence in genomics research. Throughout the course of the week, the... Read More

Industry Veteran Herman Cueto Named CFO Azenta CFO Lindon Robertson to Retire Company Reaffirms Guidance for Fourth Quarter Fiscal 2023 BURLINGTON, Mass. , Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16 . Mr. Cueto, who comes from BD (Becton, Dickinson and Company, NYSE: BDX), will... Read More

BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY , on Wednesday, September 13, 2023 , which includes a presentation beginning at 2:55 pm ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A... Read More

BURLINGTON, Mass. , Sept. 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New York, NY , on Tuesday, September 12, 2023 , which includes a presentation beginning at 9:05 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the... Read More

BURLINGTON, Mass. , Aug. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA , on Tuesday, August 15, 2023 , which includes a presentation beginning at 3:00 pm PT . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the... Read More

BURLINGTON, Mass. , Aug. 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023 . About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta... Read More

BURLINGTON, Mass. , Aug. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2023. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2023 2023 2022 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 166 $ 148 $ 133 12 % 25 % Organic growth 2 % Life Sciences Products $ 75 $ 59 $ 47 27 % 57 % Life Sciences... Read More

BURLINGTON, Mass. , Aug. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2023 earnings which ended on June 30, 2023 on Tuesday August 8, 2023 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday August 8, 2023 , at 4:30 p.m. Eastern Time . To participate in the conference call, please dial... Read More

Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint. BURLINGTON, Mass. , June 29, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it is opening a new location in the greater Boston area to expand its global sample storage... Read More

BURLINGTON, Mass. , May 30, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY , on Thursday, June 8, 2023 , which includes a presentation beginning at 11:30 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will be... Read More

Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Development of the Patient Registry Component of the Lupus Nexus BURLINGTON, Mass. , May 24, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to support the development of the... Read More

BURLINGTON, Mass. , May 17, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B. Riley Securities Institutional Investor Conference. To attend the event please contact your B. Riley Securities representative. About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful... Read More

BURLINGTON, Mass. , May 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2023 . Quarter Ended Dollars in millions, except per share data March 31, December 31, March 31, Change 2023 2022 2022 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 148 $ 178 $ 146 (17) % 2 % Organic growth ex-COVID impacts (2) % Life Sciences Products $ 59 $ 90 $ 54... Read More

BURLINGTON, Mass. , May 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2023 earnings which ended on March 31, 2023 on Tuesday, May 9, 2023 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday May 9, 2023 , at 4:30 p.m. Eastern Time . To participate in the conference call, please dial 800-926-9761... Read More

BURLINGTON, Mass. , April 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 , which includes a presentation beginning at 9:30 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast will... Read More

BURLINGTON, Mass. , March 15, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 , which includes a presentation beginning at 4:30 pm ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay... Read More

BURLINGTON, Mass. , March 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2022 . "In line with our purpose to enable life sciences... Read More

BURLINGTON, Mass. , Feb. 28, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in two upcoming investor conferences: Cowen 43rd Annual Health Care Conference in Boston, MA , on Tuesday, March 7th, 2023 . Includes a presentation beginning at 12:50 pm ET Barclays Global Healthcare Conference in Miami, FL , on Wednesday, March 15th, 2023 . Includes a presentation beginning... Read More

An Extension of Azenta's Innovative and Market Leading Automated Cryogenic Technology BURLINGTON, Mass. , Feb. 27, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many... Read More

BURLINGTON, Mass. , Feb. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-16, 2023 . To attend the event please contact your BTIG representative. About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling... Read More

Reported Q1'23 Revenue of $178 Million and Growth of 28% Year-Over-Year Delivered Organic Growth Excluding COVID of 7% Reducing Cost Structure to Deliver Two Points of Margin Enhancement in 2 nd Half FY23 BURLINGTON, Mass. , Feb. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2022 . Quarter Ended Dollars in millions, except per share data December... Read More

BURLINGTON, Mass. , Feb. 6, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on Wednesday, February 8, 2023 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, February 8, 2023 , at 4:30 p.m. Eastern Time . To participate in the conference call, please... Read More

Enhances high-throughput workflow offerings with leading 2D barcode reader BURLINGTON, Mass. , Feb. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has acquired Ziath, Ltd. and its subsidiaries ("Ziath"). Based in Cambridge, UK , Ziath is a leading provider of 2D barcode readers for life sciences... Read More

BURLINGTON, Mass. , Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA , on Wednesday, January 11, 2023 , which includes a presentation beginning at 3:45 pm PST . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay... Read More

BURLINGTON, Mass. , Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 25th Annual Needham Growth Conference in New York, NY , on Wednesday, January 11, 2023 , which includes a presentation beginning at 11:00 am ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the... Read More

CHELMSFORD, Mass. , Nov. 23, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of the Company's common stock. The ASR was entered into pursuant to the Company's previously announced $1.5 billion share repurchase authorization. In addition to the ASR, the Company... Read More

CHELMSFORD, Mass. , Nov. 21, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022 , which includes a presentation beginning at 3:30 pm ET . The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events . A replay of the webcast... Read More